Sarepta Therapeutics Inc. (SRPT)

128.98
4.80 3.90
NASDAQ : Health Technology
Prev Close 124.16
Open 124.89
Day Low/High 124.61 / 129.43
52 Wk Low/High 95.21 / 165.87
Volume 635.20K
Avg Volume 1.00M
Exchange NASDAQ
Shares Outstanding 74.15M
Market Cap 9.44B
EPS -5.50
Div & Yield N.A. (N.A)

Latest News

Noteworthy Wednesday Option Activity: SRPT, PII, BREW

Noteworthy Wednesday Option Activity: SRPT, PII, BREW

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Sarepta Therapeutics Inc , where a total volume of 5,405 contracts has been traded thus far today, a contract volume which is representative of approximately 540,500 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 51.5% of SRPT's average daily trading volume over the past month, of 1.0 million shares.

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at DexCom, HCA Healthcare, Tractor Supply, Sarepta Therapeutics, The Blackstone Group, HNI Corp. and more.

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.

Is This Market Action Foreshadowing Something Worse?

Is This Market Action Foreshadowing Something Worse?

This trading is starting to create some fairly deep pullbacks.

Sarepta Therapeutics' Charts Look Risky

Sarepta Therapeutics' Charts Look Risky

In a red flag for investors, the charts show sellers are getting more aggressive with Sarepta.

Bank of America, YY, Okta: 'Mad Money' Lightning Round

Bank of America, YY, Okta: 'Mad Money' Lightning Round

Jim Cramer weighs in on Bank of America, YY, Okta, Sarepta Therapeutics, Wendy's, ADT, New Residential Investment, First Interstate Bancshares and more.

The Perils of Stock Investing: Cramer's 'Mad Money' Recap (Thursday 3/14/19)

The Perils of Stock Investing: Cramer's 'Mad Money' Recap (Thursday 3/14/19)

On the 14th anniversary for 'Mad Money', Jim Cramer talks about how to balance owning index funds and individual stocks.

You've Got to Ask Yourself One Question: 'Do I Feel Lucky?'

You've Got to Ask Yourself One Question: 'Do I Feel Lucky?'

Luck is our constant companion in the stock market and we are fools if we ignore that fact.

The Bears Now Have Possession of the Ball After Bulls Fumble It Away

The Bears Now Have Possession of the Ball After Bulls Fumble It Away

Can they finally put some points on the board?

Sarepta Shares Surge on Positive Muscular Dystrophy Trial, Myonexus Acquisition

Sarepta Shares Surge on Positive Muscular Dystrophy Trial, Myonexus Acquisition

Shares of Sarepta Therapeutics surge after the company announces an early stage study of a gene-therapy treatment that could benefit patients with a rare form of muscular dystrophy shows promising results.

Win, With or Without China: Cramer's 'Mad Money' Recap (Monday 2/25/19)

Win, With or Without China: Cramer's 'Mad Money' Recap (Monday 2/25/19)

Jim Cramer asks whether there aren't enough good things happening that we can sustain an advance without a China deal.

Cisco Systems, Deutsche Bank, CVS: 'Mad Money' Lightning Round

Cisco Systems, Deutsche Bank, CVS: 'Mad Money' Lightning Round

Jim Cramer takes a look at Cisco Systems, Deutsche Bank, CVS, Trimble Navigation, Sarepta Therapeutics, Foot Locker, Nike and more.

Chart of the Day: Sarepta Therapeutics

If this stock breaks through resistance, we could see a powerful run towards the $200 area.

Notable Thursday Option Activity: SRPT, LCI, OFIX

Notable Thursday Option Activity: SRPT, LCI, OFIX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Sarepta Therapeutics Inc , where a total volume of 4,094 contracts has been traded thus far today, a contract volume which is representative of approximately 409,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 43.7% of SRPT's average daily trading volume over the past month, of 937,745 shares.

Fear of Missing Out Is the Main Driving Force in This Market

Fear of Missing Out Is the Main Driving Force in This Market

Stick to your methodology and don't let worry of underperformance push you to shift your approach.

The Market Is Transitioning Back to Stock Picking

The Market Is Transitioning Back to Stock Picking

There are obvious signs that people are trying to put cash to work.

Quiet Trading Allowing Some Biotech Names to Perk Up

Quiet Trading Allowing Some Biotech Names to Perk Up

After two chaotic days, Wall Street is trading relatively calmly, creating opportunities for individual names to show life.

This CEO Brought Home the Biggest Paycheck - $103 Million! So, Who Was it?

This CEO Brought Home the Biggest Paycheck - $103 Million! So, Who Was it?

CEOs of the top 350 companies, the average compensation was $18.9 million annually. So, who were the highest paid executives? Watch the video.

Who Are the 9 Highest-Paid CEOs and How Much Do They Make?

Who Are the 9 Highest-Paid CEOs and How Much Do They Make?

The CEOs who bring in the most money every year may not be who you expect. Who are the highest-paid CEOs?

Walmart Fuels Monster Move: Cramer's 'Mad Money' Recap (Thursday 8/16/18)

Walmart Fuels Monster Move: Cramer's 'Mad Money' Recap (Thursday 8/16/18)

Walmart -- with great growth -- sparks optimism, but Jim Cramer says it's not the only stock to fuel the day's rally.

Sony, United Rentals, Marathon Petroleum: 'Mad Money' Lightning Round

Sony, United Rentals, Marathon Petroleum: 'Mad Money' Lightning Round

Jim Cramer weighs in on Sony, United Rentals, Marathon Petroleum, Royal Dutch Shell, Lam Research, NuStar Energy, Ebix and more.

Why Investors Should Favor Smaller Biotech Companies

Why Investors Should Favor Smaller Biotech Companies

Small and mid-cap biotech firms are driving innovation in the sector. Experts explain why investors should take notice.

Netflix Is Tonight's Big Report: Here's How I Would Play It

Netflix Is Tonight's Big Report: Here's How I Would Play It

This is a battleground stock that has made big moves in both directions on earnings in the past.

The Market Is Not Embracing JPMorgan's Optimism

The Market Is Not Embracing JPMorgan's Optimism

The pressure on financials is affecting the entire market.

Square Continues to See Extreme Pressure

Square Continues to See Extreme Pressure

If you are interested in Square longer term be patient and wait for the drama to end.

Intel Regains Its Leadership Position in the Semiconductor Sector

Intel Regains Its Leadership Position in the Semiconductor Sector

The stock still needs to do more work to be convincing.

Overall Market Breadth Remains Negative

Overall Market Breadth Remains Negative

I'm not yet convinced that this poor action is the start of a major change in market character.

PepsiCo Isn't Going Anywhere Soon

PepsiCo Isn't Going Anywhere Soon

Blue chip name PEP is a good example of the weak action in individual stocks.

TheStreet Quant Rating: D (Sell)